Does an elderly female patient with a previously detected spot on her adrenal gland and normal bloodwork require a new computed tomography (CT) scan for further evaluation?

Does This Patient Need a New CT Scan?

No, this elderly female patient with a previously detected adrenal spot and normal bloodwork does not require a new CT scan if the lesion was initially characterized as benign (<4 cm, <10 HU on non-contrast CT, and non-functional on hormonal testing). 1, 2

Key Decision Points

If Initial Characterization Was Complete and Benign

Lesions meeting ALL of the following criteria require no further imaging or functional testing: 1, 2

• Size <4 cm (40 mm) 1, 2
• Homogeneous appearance with <10 HU on non-contrast CT 3, 1
• No hormonal hypersecretion on initial screening 1, 2
• Benign features: well-defined margins, homogeneous appearance 2

Specific benign lesions requiring no follow-up include: 1, 2

• Non-functional adenomas <4 cm 1, 2
• Myelolipomas (containing macroscopic fat) 1, 2
• Other small masses with characteristic fat content 1, 2

Critical Exception: If Initial Workup Was Incomplete

You must verify that initial hormonal evaluation was performed, even if the lesion appeared radiologically benign. 2 Approximately 5% of radiologically benign incidentalomas harbor subclinical hormone production requiring treatment. 1, 2

Required initial hormonal screening includes: 3

• Plasma aldosterone and renin activity (if hypertensive or hypokalemic) 2
• 24-hour urine metanephrines or plasma metanephrines (to exclude pheochromocytoma) 3, 4
• Screening for Cushing syndrome if clinically indicated 3

When Follow-Up CT IS Required

Repeat imaging at 6-12 months is mandatory if: 1, 2

• Lesion is ≥4 cm, even if radiologically benign, because most surgically resected pheochromocytomas and adrenocortical carcinomas were >4 cm at diagnosis 1, 2
• Initial CT was contrast-enhanced only (non-contrast CT needed for proper characterization) 3
• Lesion density was >10 HU on non-contrast CT (requires washout CT or chemical shift MRI for confirmation) 3, 2
• Patient has history of extra-adrenal malignancy (metastatic risk 25-72% depending on primary tumor) 1, 2

Growth Rate Thresholds for Ongoing Surveillance

If follow-up imaging was already performed: 1, 5

• Growth <3 mm/year: No further imaging or functional testing required 1, 5
• Growth >5 mm/year: Consider adrenalectomy after repeating functional workup 1, 5

Common Pitfalls to Avoid

Do not skip initial hormonal evaluation even for radiologically benign-appearing lesions, as subclinical hormone excess occurs in 5% of incidentalomas and requires treatment. 1, 2 This is particularly critical because undiagnosed pheochromocytoma can cause life-threatening hypertensive crisis during procedures or stress. 4

Do not perform routine adrenal biopsy for workup of adrenal incidentalomas, as it is rarely indicated and carries risks including potential tumor seeding. 1, 2

Do not apply the <4 cm "no follow-up" rule to patients with history of extra-adrenal malignancy, as these patients require closer evaluation regardless of size. 1, 2

Abdominal CT imaging is not recommended to screen for adrenal adenomas in the absence of biochemical confirmation of hormonally active tumors. 3

Practical Algorithm

1. Verify initial characterization was complete: size, density (HU), hormonal workup 3, 1, 2
2. If lesion <4 cm, <10 HU, non-functional, and no cancer history: No further imaging needed 1, 2
3. If lesion ≥4 cm OR initial workup incomplete: Obtain appropriate imaging/testing 1, 2
4. If prior follow-up showed growth <3 mm/year: Stop surveillance 1, 5